IVRS

Biotechnology Research • Scheeletorget 1, Lund, Sweden • 1-10 Employees

Company overview

Headquarters	Scheeletorget 1, Lund, Skåne 223 81, SE
Phone number	+46793172117
Website	ivrs.se
NAICS	541714
Keywords	Oncology, Drug Screening, Cell-Based Assays, In Vivo Disease Model, In Vivo Imaging 3D, Patient-Derived Studies Xenograft (Pdx) Models
Founded	2019
Employees	1-10
Socials

Key Contact at IVRS

Crystal Horn

Marketing Director

IVRS Email Formats

IVRS uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@ivrs.se), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@ivrs.se	100%

About IVRS

IVRS is an innovative preclinical CRO dedicated to accelerating drug discovery and validation for severe human diseases with significant unmet medical needs. Our expertise spans both in vitro and in vivo studies, helping to fast-track the development of breakthrough therapies. We specialize in advanced animal models for cancer, neurodegenerative diseases, and inflammatory disorders, providing: - Precise characterization of disease progression - Continuous monitoring of drug efficacy with high-throughput approaches - Visual tracking of biodistribution throughout the body and targeted organs - PK/PD profiling to optimize candidate drug performance At IVRS, our state-of-the-art technologies and disease models ensure your drug pipeline advances with accuracy and efficiency. Let us support your journey to delivering life-changing treatments.

IVRS revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,700,000
Total funding	No funding